Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States

Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories for clinical use. We sought to characterize the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson, James M., Alexander, G. Caleb, Palamuttam, Natasha, Mehta, Hemalkumar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877860/
https://www.ncbi.nlm.nih.gov/pubmed/33085221
http://dx.doi.org/10.1111/cts.12919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877860/
https://www.ncbi.nlm.nih.gov/pubmed/33085221
http://dx.doi.org/10.1111/cts.12919

Ejemplares similares